Your browser doesn't support javascript.
loading
[Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients].
Qiu, Li-Hua; Li, Yue-Yang; Zheng, Ya-Xin; Yuan, Tian; Ding, Sa; Qian, Zheng-Zi; Li, Lan-Fang; Feng, Yu-Mei; Zhang, Hui-Lai; Tian, Chen.
Affiliation
  • Qiu LH; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Li YY; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Zheng YX; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Yuan T; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Ding S; Department of Oncology, Hotan District People's Hospital of Xinjiang, Hotan 848000, Xinjiang Uygur Autonomous Region, China.
  • Qian ZZ; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Li LF; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Feng YM; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Zhang HL; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
  • Tian C; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China,Department of Oncology, Hotan District People's Hospital of Xinjiang, Hotan 848000, Xinjiang Uygur
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 29(6): 1785-1789, 2021 Dec.
Article in Zh | MEDLINE | ID: mdl-34893111
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 4, Human / Lymphoma Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 4, Human / Lymphoma Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: Zh Journal: Zhongguo Shi Yan Xue Ye Xue Za Zhi Journal subject: HEMATOLOGIA Year: 2021 Document type: Article Affiliation country: China